Cargando…

Successful treatment of acute promyelocytic leukemia in a patient undergoing hemodialysis with arsenic trioxide

A man undergoing hemodialysis was diagnosed with acute promyelocytic leukemia (APL). He received arsenic trioxide as a single agent and achieved complete molecular remission without severe adverse events. Arsenic trioxide can be used safely and effectively for patients with APL under hemodialysis.

Detalles Bibliográficos
Autores principales: Hashimoto, Akiko, Tanaka, Yasuhiro, Shinzato, Isaku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299272/
https://www.ncbi.nlm.nih.gov/pubmed/34322239
http://dx.doi.org/10.1002/ccr3.4300
Descripción
Sumario:A man undergoing hemodialysis was diagnosed with acute promyelocytic leukemia (APL). He received arsenic trioxide as a single agent and achieved complete molecular remission without severe adverse events. Arsenic trioxide can be used safely and effectively for patients with APL under hemodialysis.